Fig. 5From: The complex pathophysiology of allergic rhinitis: scientific rationale for the development of an alternative treatment option(Reprinted with permission from Klimek et al. [126])Effect of MP-AzeFlu on visual analogue scale (VAS) score over time. Data presented as mean and standard deviation. AR allergic rhinitis, CDSS clinical decision support system, MP-AzeFlu, a novel formulation of an intranasal antihistamine, azelastine hydrochloride, and an intranasal corticosteroid, fluticasone propionate, in a single sprayBack to article page